BANK OF AMERICA CORP /DE/ - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 62 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$326,717
-27.2%
21,854
-59.9%
0.00%
Q3 2022$449,000
+39.9%
54,489
+11.3%
0.00%
Q2 2022$321,000
+17.2%
48,952
-0.2%
0.00%
Q1 2022$274,000
-11.9%
49,028
-26.2%
0.00%
Q4 2021$311,000
-45.7%
66,459
-28.3%
0.00%
Q3 2021$573,000
+190.9%
92,657
+210.0%
0.00%
Q2 2021$197,000
-21.2%
29,892
-12.7%
0.00%
Q1 2021$250,000
+138.1%
34,232
+88.9%
0.00%
Q4 2020$105,000
+34.6%
18,121
+39.0%
0.00%
Q3 2020$78,000
-63.6%
13,033
-68.5%
0.00%
Q2 2020$214,000
+2040.0%
41,359
+1472.6%
0.00%
Q1 2020$10,0002,6300.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,739,255$22,544,0007.01%
Worth Venture Partners, LLC 685,026$5,638,0003.45%
NEA Management Company, LLC 3,952,957$32,533,0001.62%
Birchview Capital, LP 140,000$1,152,0000.81%
Rubric Capital Management LP 1,664,667$13,700,0000.69%
EAM Investors, LLC 380,691$3,133,0000.68%
GLOBEFLEX CAPITAL L P 368,520$3,033,0000.52%
X-Square Capital, LLC 92,283$759,0000.48%
EAM Global Investors LLC 211,759$1,743,0000.46%
J. Goldman & Co LP 656,161$5,400,0000.26%
View complete list of AVEO PHARMACEUTICALS INC shareholders